Johnson & Johnson to stop selling talc baby powder in U.S. and Canada

Reuters
Johnson & Johnson has announced it will stop selling its talc Baby Powder in the United States and Canada.
Reuters

Johnson & Johnson has announced it will stop selling its talc Baby Powder in the United States and Canada, saying demand had dropped in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges.

J&J faces more than 19,000 lawsuits from consumers and survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen. Many of the cases are pending before a US district judge in New Jersey.

“I wish my mother could be here to see this day,” said Crystal Deckard, whose mother Darlene Coker alleged Baby Powder caused her mesothelioma, a cancer that affects the lungs and chest.

 She dropped the suit filed in 1999 after losing her fight to compel J&J to divulge internal records. Coker died of mesothelioma in 2009.

In its statement, J&J said it “remains steadfastly confident in the safety of talc-based Johnson’s Baby Powder,” citing “decades of scientific studies.”

J&J has faced intense scrutiny of the safety of its baby powder following an investigative report by Reuters that found the company knew for decades that asbestos lurked in its talc.

Internal company records, trial testimony and other evidence show that from at least 1971 to the early 2000s, the company’s raw talc and finished powders sometimes tested positive for small amounts of asbestos.

The Reuters article prompted a stock selloff that erased about US$40 billion from J&J’s market value in one day and created a public relations crisis as the blue-chip healthcare conglomerate faced widespread questions about the possible health effects of one of its most iconic products.

J&J has also been the target of a federal criminal investigation into how forthright it has been about its talc products’ safety, an investigation by 41 states into its baby powder sales, which it disclosed in April, and an investigation into health risks of asbestos in talc-containing consumer products by a Congressional subcommittee.

US Representative Raja Krishnamoorthi, who led the Congressional inquiry, described J&J’s decision to stop selling talc baby powder as “a major victory for public health,” adding: “My subcommittee’s 14-month investigation revealed that Johnson & Johnson knew for decades that its product contains asbestos.”

In response to evidence of asbestos contamination presented in media reports, in the court room and on Capitol Hill, J&J has repeatedly said its talc products are safe, and do not cause cancer.

Talc, a mineral powder, is often mined in areas near asbestos deposits.

Apart from the baby powder controversy, the company revered by millions of consumers and one of the most trusted brands in America, more recently has faced a series of legal challenges.

J&J has said it has been named as a defendant, along with other drugmakers, in more than 2,900 lawsuits alleging the companies improperly promoted addictive opioids.

In August, an Oklahoma judge rendered the first verdict in that litigation, ordering J&J to pay US$572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers. J&J is appealing.

Johnson & Johnson on Tuesday said it stopped shipping talc baby powder when the COVID-19 crisis led to limits on shopping and manufacturing, and it would wind down North American sales.

Special Reports
Top